Three chronically ill patients in New York were identified as having pan-resistant C. auris after receipt of antifungal medications. No transmission of the pan-resistant isolates was found in patient contacts or the facility environments.
Date: January 10, 2020
Source: CDC Morbidity and Mortality Weekly Report
Author: Ostrowsky B, Greenko J, Adams E, et al.
Excerpt: “Three years after the first identification of C. auris in New York, pan-resistant isolates remain rare. Continued surveillance for C. auris, prudent antifungal use, and susceptibility testing for all C. auris clinical isolates (especially after patients have been treated with antifungal drugs) are needed.”
